Medcorp Limited (TTSE:MED)

Medcorp Balance Sheet

Financials in millions TTD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.1	15.3	18.64	37.62	28.05	32.1
Short-Term Investments	15.4	15	-	-	-	-
Trading Asset Securities	-	-	-	-	-	0.68
Cash & Short-Term Investments	36.5	30.3	18.64	37.62	28.05	32.79
Cash Growth	43.94%	62.56%	-50.46%	34.15%	-14.46%	-9.02%
Accounts Receivable	18.83	25.72	25.73	28.85	12.31	21.47
Other Receivables	7.39	7.18	13.66	7.21	7.99	2.51
Receivables	26.22	32.9	39.4	36.06	20.29	23.98
Inventory	9.16	8.83	7.6	6.76	7.21	7.09
Prepaid Expenses	-	0.41	0.32	0.26	-	-
Total Current Assets	71.88	72.44	65.95	80.7	55.55	63.85
Property, Plant & Equipment	132.62	141.93	156.38	168.39	73.32	63.38
Long-Term Investments	12.17	11.42	10.41	7.55	8.96	12.64
Long-Term Deferred Tax Assets	-	-	-	-	-	0.26
Total Assets	216.67	225.79	232.74	256.65	137.83	140.15

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.36	10.47	22.16	16.1	32.96	32.93
Accrued Expenses	-	6.98	8.55	7.58	12.8	7.78
Short-Term Debt	3.29	3.32	7.29	6.84	5.74	8.31
Current Portion of Long-Term Debt	-	-	2.71	5.7	5.57	4.57
Current Portion of Leases	3.26	8.87	8.48	8.53	6.3	5.96
Current Income Taxes Payable	-	1.52	1.88	6.61	3.4	6.08
Other Current Liabilities	-	3.44	4.09	4.12	4.88	2.22
Total Current Liabilities	16.91	34.6	55.16	55.5	71.65	67.86
Long-Term Debt	-	-	0.15	2.85	8.57	5.03
Long-Term Leases	86.5	88.86	98.05	107.25	17.48	23.79
Long-Term Deferred Tax Liabilities	3.44	3.44	5.52	4.66	3.32	1.89
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	106.84	126.89	158.88	170.25	101.02	98.57

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	22.18	22.18	7.48	33.41	33.41	33.41
Retained Earnings	87.66	76.73	66.38	52.99	3.4	8.17
Shareholders' Equity	109.84	98.9	73.86	86.4	36.81	41.58
Total Liabilities & Equity	216.67	225.79	232.74	256.65	137.83	140.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	93.05	101.05	116.67	131.17	43.66	47.66
Net Cash (Debt)	-56.55	-70.75	-98.03	-93.54	-15.62	-14.88
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.25	-9.24	-13.11	-12.51	-2.09	-1.99
Filing Date Shares Outstanding	7.8	7.83	7.48	7.48	7.48	7.48
Total Common Shares Outstanding	7.8	7.83	7.48	7.48	7.48	7.48
Working Capital	54.97	37.84	10.78	25.21	-16.1	-4
Book Value Per Share	14.07	12.63	9.87	11.55	4.92	5.56
Tangible Book Value	109.84	98.9	73.86	86.4	36.81	41.58
Tangible Book Value Per Share	14.07	12.63	9.87	11.55	4.92	5.56
Machinery	-	123.96	122.27	118.47	110.26	88.97
Construction In Progress	-	-	-	-	2.71	8.49
Leasehold Improvements	-	8.04	7.97	7.32	7.23	5.28

Data Source: S&P Global Market Intelligence Last updated: Nov 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error